Inactive Instrument

Stille AB Share Price Nasdaq Stockholm

Equities

SE0000998650

Medical Equipment, Supplies & Distribution

Financials

Sales 2024 * 564M 51.89M 4.33B Sales 2025 * 638M 58.64M 4.89B Capitalization 1.81B 166M 13.86B
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 3.13 x
Net cash position 2024 * 40M 3.68M 307M Net cash position 2025 * - 0 0 EV / Sales 2025 * 2.83 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 95.33%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 47 20/23/20
Director of Finance/CFO 50 01/20/01
Sales & Marketing - -
Members of the board TitleAgeSince
Director/Board Member 64 01/00/01
Director/Board Member 61 01/21/01
Chairman 52 01/20/01
More insiders
Stille AB is a Sweden-based company engaged in the development, manufacture, and marketing of technical medical equipment. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
Calendar
More about the company